246 related articles for article (PubMed ID: 31015227)
1. MicroRNA-92 Expression in CD133
Shidal C; Singh NP; Nagarkatti P; Nagarkatti M
Cancer Res; 2019 Jul; 79(14):3622-3635. PubMed ID: 31015227
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
3. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer.
Leung CON; Deng W; Ye TM; Ngan HYS; Tsao SW; Cheung ANY; Ziru N; Yuen DCK; Pang RTK; Yeung WSB
Carcinogenesis; 2020 Nov; 41(11):1592-1604. PubMed ID: 32415843
[TBL] [Abstract][Full Text] [Related]
5. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
[TBL] [Abstract][Full Text] [Related]
6. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
7. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
[TBL] [Abstract][Full Text] [Related]
8. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
[TBL] [Abstract][Full Text] [Related]
10. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.
Rappa G; Fodstad O; Lorico A
Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032
[TBL] [Abstract][Full Text] [Related]
11. Notch1-MAPK Signaling Axis Regulates CD133
Kumar D; Kumar S; Gorain M; Tomar D; Patil HS; Radharani NNV; Kumar TVS; Patil TV; Thulasiram HV; Kundu GC
J Invest Dermatol; 2016 Dec; 136(12):2462-2474. PubMed ID: 27476721
[TBL] [Abstract][Full Text] [Related]
12. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
[TBL] [Abstract][Full Text] [Related]
13. Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.
Song K; Kwon H; Han C; Zhang J; Dash S; Lim K; Wu T
Oncotarget; 2015 Dec; 6(38):40822-35. PubMed ID: 26506419
[TBL] [Abstract][Full Text] [Related]
14. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.
Yu Y; Huang R; Zong X; He X; Mo W
BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.
Xiang T; Long H; He L; Han X; Lin K; Liang Z; Zhuo W; Xie R; Zhu B
Oncogene; 2015 Jan; 34(2):165-76. PubMed ID: 24362529
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile of cancer stem‑like cells in the SW480 colon adenocarcinoma cell line.
Wang Y; Zhou L; Qing Q; Li Y; Li L; Dong X; Xiao B
Oncol Rep; 2019 Jul; 42(1):386-398. PubMed ID: 31059103
[TBL] [Abstract][Full Text] [Related]
18. miR-146a Controls Immune Response in the Melanoma Microenvironment.
Mastroianni J; Stickel N; Andrlova H; Hanke K; Melchinger W; Duquesne S; Schmidt D; Falk M; Andrieux G; Pfeifer D; Dierbach H; Schmitt-Graeff A; Meiss F; Boerries M; Zeiser R
Cancer Res; 2019 Jan; 79(1):183-195. PubMed ID: 30425059
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens.
Karatas OF; Suer I; Yuceturk B; Yilmaz M; Oz B; Guven G; Cansiz H; Creighton CJ; Ittmann M; Ozen M
BMC Cancer; 2016 Nov; 16(1):853. PubMed ID: 27816053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
